BIOMAT Database Logo BIOMAT Database Logo

Excretion of vanillylmandelic acid in renal insufficiency. 1972

S Molvalilar, and N Kocak

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014642 Vanilmandelic Acid A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE. Methoxyhydroxymandelic Acid,4-Hydroxy-3-Methoxymandelic Acid,Vanillylmandelic Acid,4 Hydroxy 3 Methoxymandelic Acid,Acid, 4-Hydroxy-3-Methoxymandelic,Acid, Methoxyhydroxymandelic,Acid, Vanillylmandelic,Acid, Vanilmandelic

Related Publications

S Molvalilar, and N Kocak
[Urine excretion of vanillylmandelic acid in patients with chronic respiratory insufficiency].
January 1971, Bratislavske lekarske listy,
S Molvalilar, and N Kocak
Renal excretion of vanillylmandelic acid and homovanillic acid in rats with paw edema or adjuvant arthritis.
January 1982, Agents and actions. Supplements,
S Molvalilar, and N Kocak
Excretion of vanilmandelic acid (VMA) in patients with renal insufficiency.
January 1965, Annales medicinae internae Fenniae,
S Molvalilar, and N Kocak
Effect of physical fitness on vanillylmandelic acid excretion during immersion.
September 1976, European journal of applied physiology and occupational physiology,
S Molvalilar, and N Kocak
Uric acid renal excretion and renal insufficiency in decompensated severe heart failure.
June 2005, European journal of heart failure,
S Molvalilar, and N Kocak
[Renal excretion of catecholamines, vanillylmandelic acid, and 17-OH-corticoids; changes after diagnostic cardiac catheterization (author's transl)].
February 1978, Casopis lekaru ceskych,
S Molvalilar, and N Kocak
[Renal excretion of calcium in chronic renal insufficiency].
November 1973, Polskie Archiwum Medycyny Wewnetrznej,
S Molvalilar, and N Kocak
17-Hydroxycorticosteroid and vanillylmandelic acid excretion in a rapidly cycling manic-depressive.
January 1968, Psychosomatic medicine,
S Molvalilar, and N Kocak
[HYDROGEN-ION EXCRETION IN RENAL INSUFFICIENCY].
January 1964, Polskie Archiwum Medycyny Wewnetrznej,
S Molvalilar, and N Kocak
[Procedures for studying the excretion of vanillylmandelic acid (review of the literature)].
January 1989, Laboratornoe delo,
Copied contents to your clipboard!